Clinical Trial

AI-Powered CURAᵀᴹ Application for Identifying At-Risk Pregnancies in Obstetric Management

Study acronym: CURAte
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
It is important to identify high pregnancies early through screening so that appropriate care and intervention may be instituted. An AI-assisted risk categorisation approach may be advantageous compared with traditional means of screening. The purpose of this study is to determine if the adoption of an AI-assisted approach in general pregnancy risk screening will improve the accuracy of antenatal risk categorization into high- and low- risk pregnancy groups, ultimately resulting in fewer poor maternal and fetal/neonatal outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-08; most recent amendment 2025-07-14.
Trial Details
NCT Number NCT06974188
Lead Sponsor National University Hospital, Singapore
Collaborators: National University of Singapore, National University of Singapore, Saw Swee Hock School of Public Health, Agency for Science, Technology and Research (A*STAR)
Conditions High-risk Pregnancy, Pregnancy, Antenatal Health
Enrollment 1,700 participants
Start Date 2025-08
Primary Completion 2026-09 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-07-15